Holiday notice: from 1pm Monday 21 September, all orders will be dispatched on Tuesday 29 September. Order as normal — everything ships the day we're back. Thank you!
ARA290 16mg
Erythropoietin-derived peptide fragment (Cibinetide), lyophilised powder (16mg, 99%+ purity) for in vitro research into tissue protection and regenerative signalling pathways.
Best value and fastest option — supplied as a lyophilised vial, dispatched same day on orders before 1pm. Use our calculator for your target concentration.
For In Vitro Use Only — Not for Human Use
Every batch is independently HPLC & mass-spec tested. Certificate of Analysis is batch-numbered and matched to the vial you receive.
Overview
ARA290 16mg is a synthetic peptide fragment derived from the erythropoietin receptor-binding domain, supplied as a lyophilised powder for laboratory research use. It is selected within controlled environments for investigation into tissue-protective signalling, receptor interaction, and regenerative pathway modelling.
Research
Within laboratory settings, ARA290 (Cibinetide) is studied for its interaction with the innate repair receptor and related protective signalling cascades. Research applications commonly focus on tissue protection, nerve-related pathway modelling, and cellular stress responses under controlled experimental conditions.
